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cAMP and cGMP levels are regulated in a highly specific and stimulus-dependent 
manner by cyclic nucleotide degrading phosphodiesterases (PDEs). Among the dif-
ferent PDEs, PDE2A is unique because it responds to elevated cGMP levels increas-
ing its cAMP hydrolytic activity. PDE2A is essential for mouse development and 
Pde2A null mice die in utero (1). Pde2A-/- embryos display a nuchal edema which 
is associated with congenital heart defects in other mouse models (2). To investi-
gate if the absence of PDE2A is associated with heart defects, macroscopical and 
microscopical observations of hearts isolated from Pde2A-/- E14.5 embryos were 
performed. Pde2A-/- hearts appeared enlarged compared to the wild type counter-
parts and displayed interventricular septum defect, hypertrabeculation, myocardial 
wall defects and atrial trabeculae loss. Increased apoptosis was detected in specific 
areas of Pde2A-/- hearts. Compromised expression pattern of critical genes involved 
in heart development (T-box genes) was observed. RT-PCR analysis revealed that 
Tbx1, Tbx2, Tbx18 and Tbx20 expression was significantly down-regulated in hearts 
from Pde2A-/- mice. To investigate whether cAMP might regulate T-box gene expres-
sion, fetal cardiomyocytes were treated with a PDE2A inhibitor (EHNA) and the 
β-adrenergic agonist Isoproterenol (Iso). T-box gene expression was down-regulated 
in cardiomyocytes treated with EHNA and Iso. Taken together these data suggest 
that PDE2A activity cannnot be replaced by other phosphodiesterases and its specific 
function could be the modulation of T-box gene expression during embryonic devel-
opment. To our knowledge, this is the first time that the genetic deletion of a phos-
phodiesterase is associated with the establishment of congenital heart defect. 
References
[1] Stephenson et al. (2009) Immunohistochemical localization of phosphodiesterase 2A in multiple 
mammalian species. J Histochem Cytochem., 57(10): 933-949.
[2] Shou et al. (2006)  Cardiac defects and altered ryanodine receptor function in mice lacking 
FKBP12. Nature 391, 489-492.  
Keywords
Pde2A. Congenital heart disease.
